Biolase Inc (BIOL)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: DENTAL EQUIPMENT & SUPPLIES

4 CROMWELL IRVINE, CA 92618

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

Data as of 2021-07-25 16:18:58 -0400
Market Cap88.54 Million Shares Outstanding150.399 Million Avg 30-day Volume1.499 Million
P/E Ratio-2.48471 Dividend Yield0.0 EPS-0.41
Price/Sales3.34 Debt to Equity1.89 EBITDA-18.839 Million
Price to Book Value2.61 Forward PE-0.19 Enterprise Value62.685 Million
Total Cash40.842 Million Current Debt11.27 Million Gross Profit7.561 Million
BETA1.08671 52-week High/Low1.51 / 0.245 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -12.9574
Data provided by IEX Cloud
View SEC Filings from BIOL instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 40 34 17.65% 9 (0.53%) 11 (0.64%) -18.18%
13F shares: 17.508 Million 7.369 Million 137.6% 5.746 Million 5.217 Million 10.14%
% Ownership 11.9932 7.8801 52.2% 3.9359 5.579 -29.45%
New Positions: 19 12 58.33% 4 5 -20.0%
Increased Positions 11 10 10.0% 4 4 0.0%
Closed Positions 12 10 20.0% 6 2 200.0%
Reduced Positions 3 4 -25.0% 1 1 0.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BIOL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BIOL BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LORD JONATHAN T MD

  • Director
519,902 2021-06-11 2

BEAVER JOHN R PRESIDENT & CEO

  • Officer
  • Director
4,144,139 2021-06-11 4

LANMAN RICHARD B.

  • Director
242,603 2021-06-11 2

SATO GARRETT

  • Director
248,888 2021-06-11 2

ROPER JESS

  • Director
249,337 2021-06-11 2

WAGNER ELAINE C

  • Director
242,603 2021-06-11 2

DITOLLA MICHAEL

  • Director
215,003 2021-06-11 2

NORBE TODD PRESIDENT AND CEO

  • Officer
  • Director
0 2020-08-06 1

FEINBERG LARRY N

ORACLE PARTNERS LP

  • 10% Owner
No longer subject to file 2020-06-08 0

SCHULER JACK W

759,820 2020-02-11 0

TALEVICH JAMES R

  • Director
20,374 2018-05-11 0

FLYNN HAROLD C JR. PRESIDENT AND CEO

  • Officer
  • Director
228,690 2017-12-05 0

FEINBERG LARRY N

ORACLE PARTNERS LP

ORACLE ASSOCIATES LLC

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
30,866,265 2017-12-04 0

MOLL FREDERIC H

  • Director
251,317 2017-06-30 0

CLARK PAUL N

  • Director
1,629,007 2017-06-30 0

FEINBERG LARRY N

ORACLE PARTNERS LP

ORACLE ASSOCIATES LLC

  • 10% Owner
18,320,650 2017-06-30 0

NELSON MARK JOSEPH SVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2017-04-18 0

SCHULER JACK W

JACK W. SCHULER LIVING TRUST

10,338,756 2016-12-29 0

DREYER DAVID C SVP / CHIEF FINANCIAL OFFICER

  • Officer
123,000 2016-07-01 0

JACK W. SCHULER LIVING TRUST

  • 10% Owner
5,885,603 2015-11-23 0

FEINBERG LARRY N

  • 10% Owner
10,529,525 2015-11-11 0

NUGENT JEFFREY M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
92,548 2014-11-03 0

SCHULER FAMILY FOUNDATION

  • 10% Owner
0 2014-11-03 0

ARROW ALEXANDER K. PRESIDENT AND COO

  • Officer
110,387 2014-07-22 0

FURRY FREDERICK D. CHIEF FINANCIAL OFFICER

  • Officer
18,020 2014-07-22 0

LOW SAMUEL BERNARD

  • Director
0 2013-12-10 0

ENRIGHT ERIN S.

  • Director
0 2013-06-07 0

NEMOY NORMAN J.

  • Director
0 2013-06-06 0

LICHTWARDT GREGORY

  • Director
0 2013-06-06 0

PIGNATELLI FEDERICO CHAIRMAN AND CEO

  • Officer
  • Director
0 2012-11-08 0

MULDER DAVID M

  • FORMER DIRECTOR AND CEO
No longer subject to file 2010-09-30 0

LAIRD NEIL J

  • FORMER DIRECTOR
No longer subject to file 2010-05-27 0

DARBELOFF GEORGE V

  • Director
0 2010-05-05 0

ANDERTON ROBERT M

  • Director
0 2010-05-05 0

LARGENT JAMES R

  • Director
0 2010-05-05 0

WALLER GREGORY D

  • Director
0 2010-05-05 0

DURRIE DANIEL S

  • Director
58,736 2009-08-25 0

CAPALLO FRED INTERIM CHIEF FINANCIAL OFF.

  • Officer
No longer subject to file 2009-08-25 0

SCOTT BRETT L CHIEF FINANCIAL OFFICER

  • Officer
0 2009-07-14 0

ST PHILIP JAKE CEO

  • Officer
  • Director
40,000 2008-05-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LORD JONATHAN T MD - Director

2021-06-14 20:50:13 -0400 2021-06-11 A 189,902 a 189,902 direct

DITOLLA MICHAEL - Director

2021-06-14 21:10:58 -0400 2021-06-11 A 104,603 a 104,603 direct

SATO GARRETT - Director

2021-06-14 21:00:32 -0400 2021-06-11 A 138,000 a 138,000 direct

LANMAN RICHARD B. - Director

2021-06-14 21:04:44 -0400 2021-06-11 A 104,603 a 104,603 direct

ROPER JESS - Director

2021-06-14 20:55:34 -0400 2021-06-11 A 111,337 a 111,337 direct

WAGNER ELAINE C - Director

2021-06-14 21:02:50 -0400 2021-06-11 A 138,000 a 138,000 direct

SATO GARRETT - Director

2021-06-14 21:00:32 -0400 2021-06-11 A 110,888 a 110,888 direct

BEAVER JOHN R - Director - Officer PRESIDENT & CEO

2021-06-14 21:35:34 -0400 2021-06-11 A 4,144,139 a 4,144,139 direct

LORD JONATHAN T MD - Director

2021-06-14 20:50:13 -0400 2021-06-11 A 330,000 a 330,000 direct

DITOLLA MICHAEL - Director

2021-06-14 21:10:58 -0400 2021-06-11 A 110,400 a 110,400 direct

WAGNER ELAINE C - Director

2021-06-14 21:02:50 -0400 2021-06-11 A 104,603 a 104,603 direct

LANMAN RICHARD B. - Director

2021-06-14 21:04:44 -0400 2021-06-11 A 138,000 a 138,000 direct

ROPER JESS - Director

2021-06-14 20:55:34 -0400 2021-06-11 A 138,000 a 138,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOLASE INC BIOL 2021-08-02 19:15:03 UTC -3.4166 3.4766 3300000
BIOLASE INC BIOL 2021-08-02 18:45:03 UTC -3.5743 3.6343 3300000
BIOLASE INC BIOL 2021-08-02 18:15:03 UTC -3.5743 3.6343 3300000
BIOLASE INC BIOL 2021-08-02 17:45:03 UTC -3.5743 3.6343 3300000
BIOLASE INC BIOL 2021-08-02 17:15:03 UTC -3.5743 3.6343 3300000
BIOLASE INC BIOL 2021-08-02 16:45:03 UTC -3.7625 3.8425 3300000
BIOLASE INC BIOL 2021-08-02 16:15:03 UTC -3.7625 3.8425 3300000
BIOLASE INC BIOL 2021-08-02 15:45:03 UTC -3.7625 3.8425 3300000
BIOLASE INC BIOL 2021-08-02 15:15:03 UTC -3.7625 3.8425 3300000
BIOLASE INC BIOL 2021-08-02 14:45:03 UTC -3.7588 3.8388 3300000
BIOLASE INC BIOL 2021-08-02 14:15:03 UTC -3.7588 3.8388 3300000
BIOLASE INC BIOL 2021-08-02 13:45:03 UTC -3.7588 3.8388 3300000
BIOLASE INC BIOL 2021-08-02 13:15:04 UTC -3.7588 3.8388 3300000
BIOLASE INC BIOL 2021-08-02 12:45:03 UTC -3.7588 3.8388 3300000
BIOLASE INC BIOL 2021-07-30 22:15:02 UTC -3.7588 3.8388 3000000
BIOLASE INC BIOL 2021-07-30 21:45:03 UTC -3.7871 3.8671 3000000
BIOLASE INC BIOL 2021-07-30 21:15:03 UTC -3.7871 3.8671 3000000
BIOLASE INC BIOL 2021-07-30 20:45:02 UTC -3.7871 3.8671 3000000
BIOLASE INC BIOL 2021-07-30 20:15:02 UTC -3.7871 3.8671 3000000
BIOLASE INC BIOL 2021-07-30 19:45:03 UTC -3.7871 3.8671 3000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BIOL -38900.0 shares, $-32788.81 2021-03-31 N-PORT

Elevate your investments